Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Depreciation & Amortization (CF) of $3.9 million for Q1 2026, up 14.05% year-on-year from $3.5 million in Q1 2025, and up 0.72% on a QoQ basis from $3.9 million in Q4 2025.
Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 14.05% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.5 million (up 25.96% YoY) and the FY2025 annual result came in at $15.0 million, up 26.6% from the prior year.
- Depreciation & Amortization (CF) rose to $3.9 million in Q1 2026 per ZLAB's latest filing, from $3.9 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for ZLAB reached as high as $3.9 million in Q1 2026 and fell as low as $1.9 million in Q2 2022.
- A 5-year average of $2.8 million and a median of $2.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) fell 13.84% — and 2024, when it surged 49.69%.
- Year by year, Depreciation & Amortization (CF) stood at $2.1 million in 2022, then advanced by 15.61% to $2.5 million in 2023, then gained by 23.3% to $3.0 million in 2024, then increased by 29.16% to $3.9 million in 2025, then advanced by 0.72% to $3.9 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.9 million, $3.9 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.92 Mn |
| Dec 31, 2025 | 3.92 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 3.46 Mn |
| Mar 31, 2025 | 3.46 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.94 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Dec 31, 2023 | 2.46 Mn |